Ferro Director Departs, Citing Performance and Governance Concerns Ferro director Michael F. Mee resigned from the company's board following the company's February 26 board meeting, raising several concerns regarding the company's performance and governance, according to an SEC filing.... Terra Industries Accepts CF Industries' Offer  Terra Industries says it has accepted CF Industries' $47.40/share offer, which was made on March 2. The offer values Terra at about $4.72 billion. Terra has informed Yara International, which offered to buy the company for $41.1/share last month, that...		Email Address First Name Last Name
People/Executives Weekly Round-Up: Dow Moving Forward In a week in which Dow Chemical agreed to sell its Styron unit to private equity firm Bain Capital, Dow CEO Andrew Liveris, sat down for a Q&A with CW. He discussed the company's challenging 2009 and its future. Dow wasn't the only company looking to the... Companies Airgas Issues Debt In Spite of Hostile Bid (Update) Airgas will issue $300 million in new senior debt in a public offering, the company announced today. The will carry an interest rate of 2.85% and come due in 2013. It will go towards paying down the company's current revolving credit facility, which expires... Emerging Companies ACC Adds Six New Members Six companies have newly joined ACC, the group announced today. The six include Clariant Corporation (Charlotte, NC), Cray Valley USA (Exton, PA), Pflaumer Brothers (Ewing, NJ), Southern Chemical (Houston), VanDeMark...	Earnings/Finance Lanxess's Third-Quarter Results Rise Sequentially; Expands Production in China  Lanxess reported third quarter net income down 59%, to €23 million ($34 million), on sales down 24%, to €1.37 billion. Ebitda before special items fell 26%, to €143 million. Lanxess's results rose sequentially, however, because of an... M&A Abbott to Acquire Facet Biotech for $450 Million Abbott Laboratories (Abbott Park, IL) says it has entered into a definitive agreement with biotechnology company Facet Biotech (Redwood City, CA), to acquire Facet Biotech for $27/share in cash, for a total transaction value of about $450 million. The... Reach Reach Registration: 'Panic is Starting to Set In' A significant number of chemical companies are starting to panic as they could miss the December 1 deadline for registering their chemical substances under the Registration, Evaluation, and Authorisation of Chemicals (Reach) program, says Jo Lloyd...

THIS ISSUE

 

CONTACT US | CUSTOMER CARE | RSS | PRIVACY POLICY | SITEMAP | ADVERTISE WITH US

Copyright © 2010 Access Intelligence LLC Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.